{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:52:48Z","timestamp":1781977968175,"version":"3.54.5"},"reference-count":42,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality, highlighting the urgent need for novel therapeutic strategies. Apoptin, encoded by the VP3 gene of the chicken anemia virus, selectively induces apoptosis in cancer cells while sparing normal cells. We previously engineered a recombinant oncolytic adenovirus (Ad-VP3) capable of high-level Apoptin expression in tumor cells. In this study, we evaluated the antitumor activity of Ad-VP3 in the human HCC cell line Hep3B. CCK-8, crystal violet, Hoechst 33342 staining, flow cytometry, and tumor sphere formation assays revealed that Ad-VP3 inhibited cell viability, proliferation, and stemness. Annexin V staining, JC-1\/TMRM probes, and Western blot analysis demonstrated induction of apoptosis and reduction of mitochondrial membrane potential. Wound-healing, Transwell, and BioCoat invasion assays, along with Western blotting, confirmed suppression of migration and invasion. Ad-VP3 significantly inhibited the viability, proliferation, migration, and invasion of Hep3B cells in a time- and dose-dependent manner. It induced mitochondrial membrane potential loss and apoptosis, downregulated stemness-related proteins (ALDH1A1, KLF4, and Sox2), and suppressed epithelial\u2013mesenchymal transition markers (Snail, Twist1, Slug, Vimentin, and MMP-9), indicating strong antitumor activity. The recombinant oncolytic adenovirus Ad-VP3 exerts potent antitumor effects on hepatocellular carcinoma cells by inducing mitochondrial dysfunctionmediated apoptosis and impairing stemness and metastatic potential, suggesting its promise as a novel therapeutic strategy for HCC.<\/jats:p>","DOI":"10.3390\/v17121636","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:13:03Z","timestamp":1765973583000},"page":"1636","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Apoptin-Armed Oncolytic Adenovirus Triggers Apoptosis and Inhibits Proliferation, Migration, Invasion, and Stemness of Hepatocellular Carcinoma Hep3B Cells"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2631-1526","authenticated-orcid":false,"given":"Zhaoxing","family":"Sun","sequence":"first","affiliation":[{"name":"Institute of Virology, Wenzhou University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Virology, Wenzhou University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"ref_1","first-page":"7","article-title":"Cancer Statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular Carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Coffin, P., and He, A. (2023). Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713274"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-020-00922-1","article-title":"Oncolytic Viruses for Cancer Immunotherapy","volume":"13","author":"Hemminki","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic Viruses: A New Class of Immunotherapy Drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/1568009618666171129221503","article-title":"Oncorine, the World First Oncolytic Virus Medicine and Its Update in China","volume":"18","author":"Liang","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Nishikawaji, Y., Kawakami, H., and Kosai, K. (2021). Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy. Viruses, 13.","DOI":"10.3390\/v13122502"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Malla, W.A., Arora, R., Khan, R.I.N., Mahajan, S., and Tiwari, A.K. (2020). Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00524"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular Carcinoma: Molecular Mechanism, Targeted Therapy, and Biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1073\/pnas.94.11.5843","article-title":"Apoptin Induces Apoptosis in Human Transformed and Malignant Cells But Not in Normal Cells","volume":"94","author":"Oorschot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bae, Y., Song, S.J., Mun, J.Y., Ko, K.S., Han, J., and Choi, J.S. (2017). Apoptin Gene Delivery by the Functionalized Polyamidoamine (PAMAM) Dendrimer Modified with Ornithine Induces Cell Death of HepG2 Cells. Polymers, 9.","DOI":"10.3390\/polym9060197"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.pharmtox.48.121806.154910","article-title":"Apoptin: Therapeutic Potential of an Early Sensor of Carcinogenic Transformation","volume":"48","author":"Backendorf","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Feng, C., Liang, Y., and Teodoro, J.G. (2020). The Role of Apoptin in Chicken Anemia Virus Replication. Pathogens, 9.","DOI":"10.3390\/pathogens9040294"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/B:APPT.0000025808.48885.9c","article-title":"The Viral Death Effector Apoptin Reveals Tumor-Specific Processes","volume":"9","author":"Rohn","year":"2004","journal-title":"Apoptosis"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"C\u00e1ceres, B., Ramirez, A., Carrillo, E., Jimenez, G., Gri\u00f1\u00e1n-Lis\u00f3n, C., L\u00f3pez-Ruiz, E., Jim\u00e9nez-Mart\u00ednez, Y., Marchal, J.A., and Boulaiz, H. (2019). Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and Apoptin. Cancers, 11.","DOI":"10.3390\/cancers11020264"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.cdd.4401391","article-title":"Human Death Effector Domain-Associated Factor Interacts with the Viral Apoptosis Agonist Apoptin and Exerts Tumor-Preferential Cell Killing","volume":"11","author":"Oorschot","year":"2004","journal-title":"Cell Death Differ."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0006-291X(03)00764-2","article-title":"The Viral Death Protein Apoptin Interacts with Hippi, the Protein Interactor of Huntingtin-Interacting Protein 1","volume":"305","author":"Cheng","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10495-015-1120-6","article-title":"Apoptin Interacts with and Regulates the Activity of Protein Kinase C Beta in Cancer Cells","volume":"20","author":"Bullenkamp","year":"2015","journal-title":"Apoptosis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-4598-9-10","article-title":"Potent Anti-Tumor Effects of a Dual Specific Oncolytic Adenovirus Expressing Apoptin In Vitro and In Vivo","volume":"9","author":"Xiao","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/jcmm.16113","article-title":"Anti-tumour Effects of a Dual Cancer-specific Oncolytic Adenovirus on Breast Cancer Stem Cells","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.7150\/ijbs.64350","article-title":"Apoptin Induces Pyroptosis of Colorectal Cancer Cells via the GSDME-Dependent Pathway","volume":"18","author":"Liu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/1568009623666221025150239","article-title":"Apoptin Inhibits Glycolysis and Regulates Autophagy by TargetingPyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells","volume":"24","author":"Song","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer Stem Cells: Advances in Knowledge and Implications for Cancer Therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e001486","DOI":"10.1136\/jitc-2020-001486","article-title":"Clinical Landscape of Oncolytic Virus Research in 2020","volume":"8","author":"Macedo","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e28729","DOI":"10.1002\/jmv.28729","article-title":"Application of Oncolytic Virus in Tumor Therapy","volume":"95","author":"Huang","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Liu, X., Yang, Z., Li, Y., Zhu, Y., Li, W., Li, S., Wang, J., Cui, Y., Shang, C., and Liu, Z. (2020). Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00229"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2017.07.013","article-title":"Advances in Cancer Stem Cell Targeting: How to Strike the Evil at Its Root","volume":"120","author":"Solanki","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yue, H., Hu, Z., Hu, R., Guo, Z., Zheng, Y., Wang, Y., and Zhou, Y. (2022). ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.918778"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lacorazza, H.D. (2025). The Reprogramming Factor KLF4 in Normal and Malignant Blood Cells. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1584181"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"44917","DOI":"10.18632\/oncotarget.16570","article-title":"The Dark Side of SOX2: Cancer\u2014A Comprehensive Overview","volume":"8","author":"Wuebben","year":"2017","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The Hallmarks of Cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"BSR20180992","DOI":"10.1042\/BSR20180992","article-title":"Apoptosis and Apoptotic Body: Disease Message and Therapeutic Target Potentials","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ucker, D.S., and Levine, J.S. (2018). Exploitation of Apoptotic Regulation in Cancer. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00241"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Pfeffer, C.M., and Singh, A.T.K. (2018). Apoptosis: A Target for Anticancer Therapy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020448"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12964-022-00940-1","article-title":"Apoptin Mediates Mitophagy and Endogenous Apoptosis by Regulating the Level of ROS in Hepatocellular Carcinoma","volume":"20","author":"Li","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10616-014-9761-9","article-title":"Distinctive Pharmacological Differences between Liver Cancer Cell Lines HepG2 and Hep3B","volume":"67","author":"Qiu","year":"2015","journal-title":"Cytotechnology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting Metastatic Cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"36435","DOI":"10.1074\/jbc.M112.397125","article-title":"Snail Represses the Splicing Regulator Epithelial Splicing Regulatory Protein 1 to Promote Epithelial-Mesenchymal Transition*","volume":"287","author":"Reinke","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1101\/gr.162933.113","article-title":"Endothelial, Epithelial, and Fibroblast Cells Exhibit Specific Splicing Programs Independently of Their Tissue of Origin","volume":"24","author":"Mallinjoud","year":"2014","journal-title":"Genome Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in Cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/12\/1636\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:14:34Z","timestamp":1765973674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/12\/1636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["v17121636"],"URL":"https:\/\/doi.org\/10.3390\/v17121636","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}